Clinical characteristics, outcome, and therapeutic effect of tafamidis in wild-type transthyretin amyloid cardiomyopathy.
Takashio S, Morioka M, Ishii M, Morikawa K, Hirakawa K, Hanatani S, Oike F, Usuku H, Kidoh M, Oda S, Yamamoto E, Matsushita K, Ueda M, Tsujita K.
Takashio S, et al. Among authors: oda s.
ESC Heart Fail. 2023 Aug;10(4):2319-2329. doi: 10.1002/ehf2.14380. Epub 2023 Apr 18.
ESC Heart Fail. 2023.
PMID: 37073415
Free PMC article.